Do ultrathin strut bare-metal stents with passive coating improve efficacy in large coronary arteries? Insights from the randomized, multicenter BASKET-PROVE trials.
Kim Wadt HansenRaban JegerRikke SørensenChristoph KaiserMatthias PfistererTor Biering-SørensenLouise Hougesen BjerkingSøren GalatiusPublished in: BMC cardiovascular disorders (2019)
In patients requiring stenting of large coronary arteries, use of the newer generation SCC-BMS was associated with a higher risk of clinically driven repeat revascularization compared to the UC-BMS with no signs of an offsetting safety benefit.
Keyphrases
- coronary artery disease
- coronary artery
- end stage renal disease
- ejection fraction
- double blind
- newly diagnosed
- chronic kidney disease
- prognostic factors
- aortic stenosis
- open label
- percutaneous coronary intervention
- heart failure
- patient reported outcomes
- acute coronary syndrome
- left ventricular
- high efficiency
- transcatheter aortic valve replacement